Page last updated: 2024-08-17

levodopa and Amentia

levodopa has been researched along with Amentia in 165 studies

Research

Studies (165)

Timeframe	Studies, this research(%)	All Research%
pre-1990	60 (36.36)	18.7374
1990's	31 (18.79)	18.2507
2000's	46 (27.88)	29.6817
2010's	22 (13.33)	24.3611
2020's	6 (3.64)	2.80

Authors

Authors	Studies
MacDonald, S; Shah, AS; Tousi, B	1
Asghar, M; Fattahi, AJ; Henriksson, AE; Khosousi, S; Miglar, A; Odeh, A; Svenningsson, P	1
Alakkas, A; Liu, L; Longardner, K; Nahab, FB; Wright, BA; Xu, R; You, H	1
Artusi, CA; Bianchini, E; De Carolis, L; Galli, S; Imbalzano, G; Ledda, C; Lopiano, L; Pontieri, FE; Rinaldi, D; Zibetti, M	1
Caparros Lefebvre, D	1
Abreu, D; Coelho, M; Fabbri, M; Ferreira, JJ	1
Bergquist, F; Dizdar, N; Grigoriou, S; Hansson, F; Johansson, A; Nyholm, D; Odin, P; Rinne, J; Sonesson, C; Svenningsson, P; Tedroff, J; Tsitsi, P; Wictorin, K	1
Chung, SJ; Lee, HS; Lee, PH; Lee, YH; Sohn, YH; Ye, BS; Yoo, HS	1
Abe, O; Aoki, S; Hattori, N; Hori, M; Ito, K; Kamagata, K; Kuwatsuru, R; Motoi, Y; Nakanishi, A; Sano, T; Sasai, K; Shimoji, K; Suzuki, M; Tomiyama, H	1
Hagiwara, M; Kasahata, N; Kato, H; Nakamura, A; Uchihara, T	1
Hattori, N	1
Marinus, J; van Hilten, JJ; Zhu, K	1
Baas, H; Gerlach, M; Kassubek, J; Müller, T; Reichmann, H; Riederer, P; Schrader, C; Urban, PP; Woitalla, D	1
Alty, JE; Clissold, BG; Ding, C; Ganesvaran, G; Kempster, PA; McColl, CD; Reardon, KA; Schiff, M; Srikanth, V	1
Ding, Z; Ge, J; Guo, S; Liu, F; Liu, Z; Tang, Y; Wang, J; Wang, Y; Wu, J; Wu, P; Zuo, C	1
Chang, MH; Chen, YH; Lee, WJ; Lin, CH; Wu, YH	1
Bi, M; Fath, T; Götz, J; Gunning, P; Ittner, LM; Ke, YD; Li, KM; van Eersel, J	1
Aarsland, D; Ballard, CG; Ehrt, U; Francis, PT; Larsen, JP; Perry, EK; Perry, RH; Piggott, MA; Sharp, SI; Ziabreva, I	1
Boecker, H; Ceballos-Baumann, AO; Drzezga, A; Förstl, H; Granert, O; Häussermann, P; Kurz, A; Perneczky, R	1
Ben-Shlomo, Y; Morris, HR; Wickremaratchi, MM	1
Devos, D	1
Abruzzese, G; Antonini, A; Bonuccelli, U; Canesi, M; Cristina, S; Defazio, G; dell'Aquila, C; Lamberti, P; Livrea, P; Logroscino, G; Marchese, R; Pacchetti, C; Zagaglia, R; Zoccolella, S	1
Alty, JE; Clissold, BG; Kempster, PA; McColl, CD; Reardon, KA; Shiff, M	1
Litvinenko, IV; Mogil'naya, VI; Odinak, MM; Perstnev, SV	1
Iliceto, G; Lamberti, P; Lamberti, SV; Logroscino, G; Santamato, A; Zoccolella, S	1
Hattori, N; Mizuno, Y; Motoi, Y; Nakamura, S; Shiotsuki, H	1
Halliday, GM; Hely, MA; Loy, C; Morris, JG; Reid, WG	1
Barker, RA; Brayne, C; Evans, JR; Foltynie, T; Mason, SL; Robbins, TW; Williams-Gray, CH	1
Gupta, D; Kuruvilla, A	1
Aarsland, D; Engedal, K; Larsson, V; Londos, E; Minthon, L; Wattmo, C	1
Schnitzler, A; Südmeyer, M; Wojtecki, L	1
Dunn, E; Espay, AJ; Gallin, E; Li, JY; Litvan, I; Morgante, F; Munhoz, RP; Teive, HA	1
Inoue, Y; Kagimura, T; Nakashima, K; Nomura, T	1
Fukushima, FB; Valle, AP; Vidal, EI; Villas Boas, PJ	1
Alty, JE; Clissold, BG; Ganga, G; Kempster, PA; McColl, CD; Reardon, KA; Schiff, M	1
Adler, CH; Beach, TB; Caviness, JN; Gurevich, EV; Joyce, JN; Reiser, M; Ryoo, HL; Stacy, M	1
Arima, K; Baker, M; Delisle, MB; Ghetti, B; Hutton, ML; Kobayashi, T; Komure, O; Kuno, S; Mizuno, Y; Murrell, JR; Rascol, O; Soulages, X; Sunohara, N; Tsuboi, Y; Uitti, RJ; Wszolek, ZK; Yasuda, M	1
Ferrannini, E; Fraddosio, A; Iliceto, G; Lamberti, S; Maggio, F; Palagano, G; Russo, I; Serlenga, L; Zoccolella, S	1
Farrer, MJ; Hulihan, M; Hussey, JM; Krygowska-Wajs, A; Tsuboi, Y; Uitti, RJ; Wszolek, ZK	1
Matsushima, E; Nakashima, K; Shimizu, Y; Urakami, K; Watanabe, Y	1
Kuzuhara, S; Naito, Y	1
Bonelli, SB; Deibl, M; Lampl, C; Lukas, T; Ransmayr, G; Steffelbauer, M	1
Lang, AE; Postuma, RB	1
Giladi, N; Korczyn, AD; Merims, D; Peretz, C; Shabtai, H; Weizman, N	1
Hely, MA; Morris, JG; Reid, WG; Trafficante, R	1
Iakhno, NN; Zakharov, VV	1
Inzelberg, R; Paleacu, D; Schechtman, E	1
al-Din, AS; Hadeed, A; Lees, AJ; Williams, DR; Wreikat, AL	1
Burn, DJ; Firbank, MJ; McKeith, IG; O'Brien, JT	1
Bleda, MJ; Serrano-Dueñas, M	1
Ludin, HP	1
Fénelon, G; Goetz, CG; Karenberg, A	1
Atsumi, M; Hattori, N; Li, Y; Sato, K; Tomiyama, H	1
Brodsky, MA; Koudelka, C; Swarztrauber, K	1
Giladi, N; Gurevich, TY; Korczyn, AD; Shabtai, H; Simon, ES	1
Ransmayr, G	1
Waldvogel, D	1
Damier, P; Meyniel, C	1
Kaneda, D; Oyanagi, K; Shintaku, M	1
Levy, G	1
Aydemir, T; Cetin, S; Erol, C; Hanoglu, L; Meral, H; Ozben, S; Ozer, F; Ozkayran, T; Ozturk, O; Yilsen, M	1
Berrutti, M; Fagoonee, S; Pellicano, R; Rizzetto, M; Saracco, G	1
Muthane, U; Ragothaman, M	1
Brown, P; Doyle, LM; Lees, AJ; Williams, DR	1
Adena, MA; Halliday, GM; Hely, MA; Morris, JG; Reid, WG	1
Chan, DK; Cordato, DJ; O'Rourke, F	1
Fisman, M	1
Bjørndal, N; Casey, DE; Gerlach, J	1
MacDonald, E; Rekonen, M; Riekkinen, PJ; Soininen, H	1
Frackowiak, RS; Gibbs, JM; Jones, T; Lammertsma, AA; Leenders, KL	1
Mayeux, R; Stern, Y	1
Blair, RD; Lang, AE	1
Gerber, JC; Grossman, MH; Hare, TA; Katz, L; Manyam, NV	1
Selby, G	1
Burns, R	1
Birkmayer, W; Danielczyk, W; Riederer, P	1
Cote, L; Fahn, S; Lobo Antunes, J	1
Rinne, UK	1
Aitken, JA; Turnbull, CJ	1
Chase, TN; Chen, KM; Doi, H; Uebayashi, Y; Yanagihara, RT	1
Portin, R; Raininko, R; Rinne, UK	1
Beard, CM; Kurland, LT; Offord, K; Rajput, AH	1
Coignet, A; de Recondo, J; Rondot, P; Ziegler, M	1
Rajput, AH	1
Klawans, HL	2
Agid, Y; de Smet, Y; Dubois, B; Lhermitte, F; Ruberg, M; Serdaru, M	1
Barnes, TR; White, NJ	1
Calliauw, J; Konings, CH; Kuiper, MA; Mulder, C; Wolters, EC	1
Kawabata, K; Okuda, B; Sugita, M; Tachibana, H; Takeda, M	1
Calabrese, P; Durwen, HF; Gehlen, W; Holinka, B; Markowitsch, HJ	1
Corey-Bloom, J; Galasko, D; Olichney, JM; Thal, LJ	1
Block, RE; Bowen, BC; Lampman, DA; Murdoch, JB; Pattany, PM; Quencer, RM; Sanchez-Ramos, J	1
Dasouki, M; Hiari, M; Mubaidin, A; Najim al-Din, AS; Wriekat, A	1
Cooper, JA; Sagar, HJ; Sullivan, EV	1
Coakley, D; Feely, J; O'Mahony, D; O'Neill, D; Rowan, M; Walsh, JB	1
Marder, K; Mayeux, R; Stern, Y; Tang, MX	1
Lange, KW; Marsden, CD; Paul, GM; Robbins, TW	1
Daniel, SE; Hughes, AJ; Lees, AJ	1
Bösch, S; Kreczy-Kleedorfer, B; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M	1
Cote, L; Fahn, S; Greene, P	1
Blankson, S; Daniel, SE; Hughes, AJ; Lees, AJ	1
Baas, H; Fischer, PA; Stecker, K	1
Di Rocco, A; Kollmeier, B; Molinari, SP; Yahr, MD	1
Dickson, DW; Duvoisin, RC; Mark, MH; Sage, JI	1
Bermejo, F; Del Ser, T; Pondal, M	1
Camicioli, R; Ganzini, L; Young, BK	1
Dobato, JL; Giménez-Roldán, S; Mateo, D	1
Antkiewicz-Michaluk, L; Krygowska-Wajs, A; Romańska, I; Szczudlik, A; Vetulani, J	1
Friedman, JH; Growdon, JH; Kieburtz, K; McDermott, MP; Panisset, M	1
Calne, DB; Caselli, RJ; Forno, LS; Hornykiewicz, O; Howard, FM; Kish, SJ; Maraganore, DM; Muenter, MD; Okazaki, H; Snow, BJ	1
Gwinn-Hardy, K; Hardy, J	1
Giladi, N; Kandinov, B; Korczyn, AD; Orlov, Y; Paleacu, D; Shabtai, H; Simon, ES; Treves, TA	1
Karlsen, K; Larsen, JP; Tandberg, E	1
Prabhakar, S; Srivastava, T; Syal, P	1
Cabral, J; Gálvez-Jiménez, N; Hanson, MR	1
Cyong, J; Itokazu, N; Ouchi, Y; Yamamoto, K	1
Hashimoto, T; Hayashi, R; Ikeda, S; Tada, T	1
Goetz, CG; Leurgans, S; Pappert, EJ; Raman, R; Stemer, AB	1
Abe, Y; Arahata, Y; Brooks, DJ; Hatano, K; Ito, K; Kachi, T; Kato, T; Kawasumi, Y; Nagano-Saito, A; Nakamura, A; Yamada, T	1
Danielczyk, W	1
Drachman, DA; Stahl, S	1
Rajput, AH; Rozdilsky, B	1
Pearce, I; Pearce, J	1
Kristensen, V	1
Bonduelle, M; Degos, CF	1
Ballinger, BR; Lewis, C; Presly, AS	1
Dziatolowski, M; Goldstein, M; Goodgold, A; Korein, J; Kupersmith, M; Lieberman, A; Serby, M	1
Ballinger, BR; Johnson, K; Presly, AS	1
Clough, G; Jerram, T; Renvoize, EB	1
Kristensen, V; Olsen, M; Theilgaard, A	1
Feigenson, JS; Goodell, H; Loranger, AW; McDowell, FH; Sweet, RD	1
Brody, JA; Kurland, LT; Stanhope, JM	1
Reid, WG	1
Dethlefsen, J; Vieregge, P	1
Bordet, R; Destée, A	1
Caraceni, T; Geminiani, G; Genitrini, S; Giovannini, P; Girotti, F; Piccolo, I; Scigliano, G; Soliveri, P	1
Cedarbaum, JM; Gandy, SE; McDowell, FH	1
Korczyn, A; Salganik, I	1
Artieda, J; Grandas, F; Lera, G; Luquin, MR; Martinez-Lage, JM; Obeso, JA; Rodriguez, ME; Vaamonde, J	1
Dubois, B	1
Duret, M; Goldman, S; Hildebrand, J; Messina, D	1
Harvey, NS	1
Genovese, N; Klawans, HL	1
Caltagirone, C; Carlesimo, A; Nocentini, U; Vicari, S	1
Eadie, MJ	1
Leicester, J; Morris, J; Pamphlett, R	1
Hietanen, M; Teräväinen, H	1
Fukuda, H; Fukuyama, H; Hara, K; Kameyama, M; Nakamura, S	1
Akiguchi, I; Itoh, H; Kameyama, M; Nakamura, S; Yamao, S	1
Nashef, L; Rose, FC	1
Gerstenbrand, F; Ransmayr, G	1
Gottfries, CG	1
Critchley, P; Marsden, CD; Quinn, N	1
Diamond, SG; Markham, CH	1
Gerstenbrand, F; Poewe, W	1
Portin, R; Rinne, UK	1
Cedarbaum, JM; McDowell, FH	1
Kameyama, M; Kato, T	1
Gaskell, RK; Klar, HM; Renvoize, EB	1
Rosin, AJ	1
Diamond, SG; Markham, CH; Treciokas, LJ	1

Reviews

32 review(s) available for levodopa and Amentia

Article	Year
Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update. Drugs & aging, 2022, Volume: 39, Issue:7 Topics: Dementia; Drug Development; Humans; Levodopa; Lewy Body Disease; Parkinson Disease	2022
Food toxins and the Caribbean Parkinson plus types. Revue neurologique, 2019, Volume: 175, Issue:10 Topics: Annonaceae; Caribbean Region; Dementia; Drug Resistance; Food; Guadeloupe; Humans; Levodopa; Martinique; Parkinson Disease; Parkinsonian Disorders; Teas, Herbal; West Indies	2019
[Programs for continuing medical education: a session: 4. The pathogenesis and update for the treatments of Parkinson's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Benserazide; Benzothiazoles; Catechols; Circadian Rhythm; Dementia; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Dyskinesias; Education, Medical, Continuing; Hallucinations; Humans; Levodopa; Nitriles; Parkinson Disease; Practice Guidelines as Topic; Pramipexole; Reference Standards; Referral and Consultation	2014
Laboratory assessments in the course of Parkinson's disease: a clinician's perspective. Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:1 Topics: Clinical Laboratory Techniques; Confusion; Dementia; Diagnosis, Differential; Humans; Levodopa; Parkinson Disease; Psychotic Disorders; Vitamins	2016
The effect of onset age on the clinical features of Parkinson's disease. European journal of neurology, 2009, Volume: 16, Issue:4 Topics: Adult; Age of Onset; Aged; Dementia; Disease Progression; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Middle Aged; Parkinson Disease; Phenotype; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? Current medicinal chemistry, 2010, Volume: 17, Issue:28 Topics: Antiparkinson Agents; Cognition Disorders; Dementia; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Neurons; Parkinson Disease	2010
Vascular parkinsonism: what makes it different? Postgraduate medical journal, 2011, Volume: 87, Issue:1034 Topics: Antiparkinson Agents; Brain Ischemia; Dementia; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease, Secondary	2011
[Current treatment strategies for Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:12 Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor	2011
[Drug induced dementia--anti-parkinsonian drugs]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl Topics: Antiparkinson Agents; Basal Ganglia; Cerebral Cortex; Cholinergic Antagonists; Dementia; Hallucinations; Humans; Levodopa; Neurotransmitter Agents	2004
Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? Neurology, 2004, Sep-14, Volume: 63, Issue:5 Topics: Antiparkinson Agents; Arteriosclerosis; Catechol O-Methyltransferase; Dementia; Disease Progression; Disease Susceptibility; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Levodopa; Models, Biological; Multicenter Studies as Topic; Oxidative Stress; Parkinson Disease; Randomized Controlled Trials as Topic; Substantia Nigra	2004
[Idiopathic Parkinson's disease: practical hints for the treatment]. Praxis, 2005, Jul-27, Volume: 94, Issue:30-31 Topics: Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Benserazide; Cholinesterase Inhibitors; Clozapine; Dementia; Depression; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease; Quality of Life; Sleep Wake Disorders; Time Factors	2005
[Clinical criteria of Parkinson's disease]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:1 Topics: Age Factors; Aged; Antiparkinson Agents; Cognition Disorders; Dementia; Diagnosis, Differential; Dopamine Agonists; Humans; Levodopa; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2007
[Medical treatment of Parkinson's disease]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:1 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Cholinergic Antagonists; Controlled Clinical Trials as Topic; Dementia; Depression; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Dyskinesias; Hallucinations; Humans; Levodopa; Middle Aged; Multicenter Studies as Topic; Pain; Parkinson Disease; Quality of Life; Therapeutic Equivalency; Time Factors	2007
[Lewy body dementia and Parkinson disease dementia]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:10 Pt 2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Dementia; Diagnosis, Differential; Disease Progression; Dopamine Agents; Humans; Iatrogenic Disease; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Parkinsonian Disorders; Phenylcarbamates; Psychotropic Drugs; Rivastigmine; Serotonin Antagonists	2007
The relationship of Parkinson disease with aging. Archives of neurology, 2007, Volume: 64, Issue:9 Topics: Aging; Antiparkinson Agents; Cognition Disorders; Dementia; Disease Progression; Gait; Humans; Levodopa; Parkinson Disease; Posture	2007
Helicobacter pylori and dementia. Which consistency for an association? Panminerva medica, 2007, Volume: 49, Issue:4 Topics: Absorption; Animals; Dementia; Helicobacter Infections; Helicobacter pylori; Humans; Levodopa; MEDLINE; Models, Biological	2007
Management for motor and non-motor complications in late Parkinson's disease. Geriatrics, 2008, Volume: 63, Issue:5 Topics: Accidental Falls; Aged; Antiparkinson Agents; Comorbidity; Dementia; Dyskinesias; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Sleep Wake Disorders	2008
Clinical pharmacology of senile dementia. Progress in neuro-psychopharmacology, 1981, Volume: 5, Issue:5-6 Topics: Aged; Aging; Anticoagulants; Arginine Vasopressin; Brain; Choline; Dementia; Dihydroergotoxine; Free Radicals; Glucose; Humans; Levodopa; Neurotransmitter Agents; Vasodilator Agents; Xanthinol Niacinate	1981
Positron emission tomography of the brain: new possibilities for the investigation of human cerebral pathophysiology. Progress in neurobiology, 1984, Volume: 23, Issue:1-2 Topics: Aging; Amino Acids; Arterial Occlusive Diseases; Brain; Brain Ischemia; Brain Neoplasms; Carotid Artery Diseases; Cerebral Infarction; Cerebrovascular Disorders; Dementia; Epilepsy; Fluorine; Forecasting; Homeostasis; Humans; Huntington Disease; Isotopes; Levodopa; Mental Disorders; Models, Biological; Neurology; Oxygen Radioisotopes; Parkinson Disease; Radioisotopes; Receptors, Drug; Reference Values; Respiration; Tomography, Emission-Computed	1984
Intellectual dysfunction and dementia in Parkinson disease. Advances in neurology, 1983, Volume: 38 Topics: Aged; Atrophy; Basal Ganglia; Cerebral Cortex; Dementia; Humans; Intelligence; Levodopa; Middle Aged; Parkinson Disease; Psychological Tests	1983
Parkinson's disease in 1984: an update. Canadian Medical Association journal, 1984, Nov-01, Volume: 131, Issue:9 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Dementia; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Primates; Psychoses, Substance-Induced; Pyridines; Receptors, Dopamine; Time Factors	1984
[Neuropsychological aspects in idiopathic Parkinson disease]. Fortschritte der Neurologie-Psychiatrie, 1995, Volume: 63, Issue:2 Topics: Aged; Brain Damage, Chronic; Dementia; Depressive Disorder; Humans; Levodopa; Neuropsychological Tests	1995
The spectrum of diseases with diffuse Lewy bodies. Advances in neurology, 1995, Volume: 65 Topics: Age Factors; Alzheimer Disease; Basal Ganglia Diseases; Cerebral Cortex; Dementia; Humans; Levodopa; Lewy Bodies	1995
L-dopa and frontal cognitive function in Parkinson's disease. Advances in neurology, 1993, Volume: 60 Topics: Aged; Dementia; Frontal Lobe; Humans; Levodopa; Mental Processes; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Substance Withdrawal Syndrome	1993
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment. Drugs & aging, 1997, Volume: 10, Issue:5 Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Dementia; Depression; Dopamine Agonists; Electroconvulsive Therapy; Humans; Levodopa; Memantine; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Risk Factors; Serotonin Antagonists	1997
Patterns of Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia on Guam. Contemporary neurology series, 1975, Volume: 12 Topics: Adult; Aged; Amines; Amyotrophic Lateral Sclerosis; Autopsy; Dementia; Demography; Environmental Pollutants; Ethnicity; Female; Gene Frequency; Guam; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Toxins, Biological	1975
[From Parkinson's disease to Lewy body disease]. Presse medicale (Paris, France : 1983), 1992, Apr-18, Volume: 21, Issue:15 Topics: Alzheimer Disease; Dementia; Depressive Disorder; Humans; Levodopa; Lewy Bodies; Parkinson Disease	1992
Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Dementia; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychomotor Performance; Psychoses, Substance-Induced	1989
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions. Psychosomatics, 1986, Volume: 27, Issue:3 Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception	1986
Pharmacology of dementia. Neurologic clinics, 1986, Volume: 4, Issue:2 Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins	1986
[Therapy of dementia in the aged]. Nihon rinsho. Japanese journal of clinical medicine, 1985, Volume: 43, Issue:7 Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Central Nervous System Diseases; Dementia; Humans; Levodopa; Middle Aged; Parasympathomimetics; Psychotropic Drugs; Rats; Synapses	1985
Parkinson's disease and levodopa. A five-year follow-up and review. The Western journal of medicine, 1974, Volume: 121, Issue:3 Topics: Activities of Daily Living; Adolescent; Adult; Aged; Animals; Athetosis; Basal Ganglia; Chorea; Corpus Striatum; Dementia; Depression; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Sexual Behavior; Substantia Nigra; Vomiting	1974

Trials

16 trial(s) available for levodopa and Amentia

Article	Year
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia. Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:6 Topics: Antiparkinson Agents; Cerebral Cortex; Dementia; Double-Blind Method; Humans; Levodopa; Parkinson Disease	2020
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia. Movement disorders : official journal of the Movement Disorder Society, 2009, May-15, Volume: 24, Issue:7 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Dementia; Female; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Logistic Models; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease	2009
Longitudinal study of the levodopa motor response in Parkinson's disease: relationship between cognitive decline and motor function. Movement disorders : official journal of the Movement Disorder Society, 2009, Dec-15, Volume: 24, Issue:16 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Parkinsonian Disorders; Statistics, Nonparametric	2009
Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia. Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Homocysteine; Humans; Levodopa; Memantine; Neuropsychological Tests; Nootropic Agents; Parkinson Disease; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2010
Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders, 2011, Volume: 32, Issue:4 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Levodopa; Lewy Body Disease; Male; Memantine; Neuropsychological Tests; Parkinson Disease; Quality of Life; Treatment Outcome	2011
Parkinson's disease: progression and mortality in the L-DOPA era. Advances in neurology, 1996, Volume: 69 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Cause of Death; Dementia; Disease Progression; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Levodopa; Life Expectancy; Male; Middle Aged; Parkinson Disease; Survival Analysis	1996
The clinicopathologic spectrum of Lewy body disease. Advances in neurology, 1996, Volume: 69 Topics: Adolescent; Aged; Antiparkinson Agents; Brain; Dementia; Family; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Nervous System Diseases; Parkinson Disease	1996
Anticholinergic therapy and dementia in patients with Parkinson's disease. Journal of neurology, 1996, Volume: 243, Issue:7 Topics: Adult; Aged; Cholinergic Antagonists; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1996
Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology. Biological psychiatry, 1997, Sep-15, Volume: 42, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dementia; Female; Homovanillic Acid; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Tyrosine	1997
P300 in newly diagnosed non-dementing Parkinson's disease: effect of dopaminergic drugs. Neurology India, 2000, Volume: 48, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Cognition; Dementia; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Predictive Value of Tests; Prognosis; Reaction Time	2000
Trial of levodopa in senile dementia. British medical journal, 1978, Mar-04, Volume: 1, Issue:6112 Topics: Aged; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Humans; Intelligence; Levodopa	1978
Levodopa treatment of presenile dementia. Acta psychiatrica Scandinavica, 1977, Volume: 55, Issue:1 Topics: Adult; Cognition Disorders; Dementia; Drug Evaluation; Female; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Wechsler Scales	1977
Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology, 1976, Volume: 26, Issue:4 Topics: Adult; Aged; Delirium; Dementia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Tryptophan	1976
The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes. International psychogeriatrics, 1992, Volume: 4 Suppl 2 Topics: Age Factors; Aged; Bromocriptine; Carbidopa; Dementia; Drug Therapy, Combination; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease	1992
Effect of L-dopa on dementia-related rigidity. Acta neurologica Scandinavica, 1989, Volume: 80, Issue:1 Topics: Aged; Aged, 80 and over; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity	1989
Pharmacology of dementia. Neurologic clinics, 1986, Volume: 4, Issue:2 Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins	1986

Other Studies

118 other study(ies) available for levodopa and Amentia

Article	Year
Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia. Scientific reports, 2022, 10-20, Volume: 12, Issue:1 Topics: Cellular Senescence; Dementia; DNA, Mitochondrial; Humans; Levodopa; Lewy Body Disease; Organelle Biogenesis; Parkinson Disease; Telomere	2022
Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis. PloS one, 2023, Volume: 18, Issue:1 Topics: Aged; Antipsychotic Agents; Dementia; Humans; Levodopa; Parkinson Disease; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Urea	2023
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel. Parkinsonism & related disorders, 2023, Volume: 109 Topics: Antiparkinson Agents; Carbidopa; Deglutition Disorders; Dementia; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Retrospective Studies	2023
Levodopa response in later stages of Parkinson's disease: A case-control study. Parkinsonism & related disorders, 2020, Volume: 77 Topics: Aged; Antiparkinson Agents; Case-Control Studies; Dementia; Disease Progression; Female; Humans; Levodopa; Male; Parkinson Disease	2020
Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD. Neurology, 2019, 03-26, Volume: 92, Issue:13 Topics: Aged; Antiparkinson Agents; Cognitive Dysfunction; Cohort Studies; Dementia; Disease Progression; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Proportional Hazards Models; Retrospective Studies	2019
Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis. European radiology, 2013, Volume: 23, Issue:7 Topics: Aged; Anisotropy; Brain; Brain Mapping; Case-Control Studies; Cognition; Cognition Disorders; Corpus Callosum; Dementia; Diffusion Tensor Imaging; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Nerve Fibers, Myelinated; Parkinson Disease	2013
An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies. Journal of Alzheimer's disease : JAD, 2014, Volume: 39, Issue:3 Topics: Aged, 80 and over; Alzheimer Disease; Amphetamine; Dementia; Humans; Imaging, Three-Dimensional; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	2014
Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG. Parkinsonism & related disorders, 2014, Volume: 20, Issue:9 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Cohort Studies; Cross-Sectional Studies; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Risk Factors	2014
Study of levodopa response in Parkinson's disease: Observations on rates of motor progression. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:4 Topics: Aged; Antiparkinson Agents; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Severity of Illness Index	2016
Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease. PloS one, 2016, Volume: 11, Issue:4 Topics: Aged; Brain; Cerebral Cortex; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography	2016
Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study. PloS one, 2016, Volume: 11, Issue:8 Topics: Case-Control Studies; Comorbidity; Databases, Factual; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pneumonia, Aspiration; Prognosis; Psychotic Disorders; Risk Factors; Taiwan	2016
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proceedings of the National Academy of Sciences of the United States of America, 2008, Oct-14, Volume: 105, Issue:41 Topics: Animals; Axonal Transport; Dementia; Disease Models, Animal; Frontal Lobe; Humans; Levodopa; Mice; Mice, Transgenic; Motor Skills Disorders; Mutation, Missense; Parkinsonian Disorders; Phenotype; Sciatic Nerve; Substantia Nigra; tau Proteins; Temporal Lobe	2008
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Autopsy; Cerebral Cortex; Dementia; Depression; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Temporal Lobe	2008
Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease. Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:5 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Brain Chemistry; Cognition; Data Interpretation, Statistical; Dementia; Education; Female; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Levodopa; Lewy Body Disease; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography	2008
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, May-15, Volume: 24, Issue:7 Topics: Aged; Antiparkinson Agents; Dementia; Duodenum; Female; Gait Disorders, Neurologic; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Personal Autonomy; Quality of Life; Retrospective Studies; Treatment Outcome	2009
Dopamine deficiency may lead to capgras syndrome in Parkinson's disease with dementia. The Journal of neuropsychiatry and clinical neurosciences, 2010,Summer, Volume: 22, Issue:3 Topics: Antiparkinson Agents; Capgras Syndrome; Dementia; Dopamine; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Treatment Outcome	2010
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study). Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:9 Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Humans; Levodopa; Longitudinal Studies; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; New South Wales; Parkinson Disease; Survival Analysis	2011
The natural history of treated Parkinson's disease in an incident, community based cohort. Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:10 Topics: Age Factors; Aged; Antiparkinson Agents; Dementia; Disease Progression; Female; Genotype; Haplotypes; Humans; Kaplan-Meier Estimate; Levodopa; Male; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Quality of Life; tau Proteins	2011
Long-duration Parkinson's disease: role of lateralization of motor features. Parkinsonism & related disorders, 2013, Volume: 19, Issue:1 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Case-Control Studies; Dementia; Disease Progression; Female; Functional Laterality; Humans; Levodopa; Longevity; Male; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Tremor	2013
Clinical significance of REM sleep behavior disorder in Parkinson's disease. Sleep medicine, 2013, Volume: 14, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Autonomic Nervous System; Blood Pressure; Cross-Sectional Studies; Dementia; Disability Evaluation; Dose-Response Relationship, Drug; Female; Heart; Humans; Hypotension, Orthostatic; Kaplan-Meier Estimate; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Polysomnography; Prognosis; Proportional Hazards Models; REM Sleep Behavior Disorder; Sleep Stages; Tilt-Table Test	2013
Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia. Journal of the American Geriatrics Society, 2013, Volume: 61, Issue:1 Topics: Aged, 80 and over; Antiparkinson Agents; Dementia; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Memantine; Middle Aged; Parkinson Disease	2013
Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dementia; Disease Progression; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Subthalamic Nucleus; Treatment Outcome	2013
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors. Brain research, 2002, Nov-15, Volume: 955, Issue:1-2 Topics: Aged; Aged, 80 and over; Analysis of Variance; Corpus Striatum; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine D2; Receptors, Dopamine D3; Retrospective Studies; RNA, Messenger; Tyrosine 3-Monooxygenase	2002
Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology, 2002, Dec-10, Volume: 59, Issue:11 Topics: Adult; Antiparkinson Agents; Chromosomes, Human, Pair 17; Dementia; DNA; Founder Effect; France; Frontal Lobe; Humans; Japan; Levodopa; Male; Microsatellite Repeats; Molecular Biology; Mutation; Nerve Degeneration; Parkinson Disease; Penetrance; tau Proteins; Temporal Lobe; United States	2002
ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2 Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Dementia; Female; Humans; Levodopa; Male; Parkinsonian Disorders	2002
Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci. Parkinsonism & related disorders, 2003, Volume: 9, Issue:4 Topics: Activities of Daily Living; Adult; Age of Onset; Aged; Antiparkinson Agents; Dementia; Disease Progression; Female; Genetic Linkage; Humans; Levodopa; Male; Middle Aged; Molecular Biology; Parkinsonian Disorders; Pedigree; Phenotype; Poland; Urinary Incontinence	2003
Vertical ophthalmoplegia in a demented patient with striatopallidodentate calcification. Psychiatry and clinical neurosciences, 2003, Volume: 57, Issue:4 Topics: Aged; Amyloid beta-Peptides; Calcinosis; Dementia; Dentate Gyrus; Dopamine Agents; Enzyme-Linked Immunosorbent Assay; Globus Pallidus; Humans; Levodopa; Male; Neostriatum; Ophthalmoplegia; Psychiatric Status Rating Scales; Psychomotor Performance; Tomography, X-Ray Computed	2003
L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Aged; Aged, 80 and over; Dementia; Dopamine Agonists; Female; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease; Predictive Value of Tests; Prospective Studies	2004
Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:10-11 Topics: Adult; Aged; Aged, 80 and over; Aging; Antiparkinson Agents; Dementia; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Risk Factors; United Kingdom	2004
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Dementia; Disease Progression; Dose-Response Relationship, Drug; Employment; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Mortality; Movement Disorders; Multicenter Studies as Topic; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Time Factors	2005
[Cognitive dysfunction in patients with Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:1 Topics: Aged; Antiparkinson Agents; Cholinergic Antagonists; Cognition Disorders; Dementia; Dopamine Agonists; Female; Frontal Lobe; Functional Laterality; Hippocampus; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index	2005
Association between family history of dementia and hallucinations in Parkinson disease. Neurology, 2005, May-24, Volume: 64, Issue:10 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Cross-Sectional Studies; Dementia; DNA Mutational Analysis; Female; Genetic Testing; Hallucinations; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prevalence; Risk Factors; Surveys and Questionnaires; Ubiquitin-Protein Ligases	2005
Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:10 Topics: Adolescent; Adult; Age of Onset; Antiparkinson Agents; Child; Chromosomes, Human, Pair 1; Dementia; Female; Functional Laterality; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Pedigree; Pyramidal Tracts; Severity of Illness Index; Supranuclear Palsy, Progressive	2005
Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. International journal of geriatric psychiatry, 2005, Volume: 20, Issue:8 Topics: Aged; Antiparkinson Agents; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Lewy Body Disease; Longitudinal Studies; Male; Motor Activity; Parkinson Disease; Psychological Tests; Tomography, Emission-Computed, Single-Photon	2005
Delirium in Parkinson's disease patients. a five-year follow-up study. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Delirium; Dementia; Female; Follow-Up Studies; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Risk Factors; Survival Analysis	2005
Hallucinations in Parkinson disease in the prelevodopa era. Neurology, 2006, Jan-10, Volume: 66, Issue:1 Topics: Affective Symptoms; Brain; Dementia; Dopamine; Dopamine Agents; Hallucinations; History, 19th Century; History, 20th Century; Humans; Levodopa; Neurology; Parkinson Disease; Psychotic Disorders	2006
[A 62-year-old woman with early-onset Parkinson's disease associated with the PINKi gene deletion]. Rinsho shinkeigaku = Clinical neurology, 2006, Volume: 46, Issue:3 Topics: Age Factors; Antiparkinson Agents; Dementia; Dystonia; Female; Gene Deletion; Humans; Levodopa; Middle Aged; Mutation; Parkinson Disease; Protein Kinases	2006
Initial pharmacotherapy in a population of veterans with Parkinson disease. Neurology, 2006, May-09, Volume: 66, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Cholinergic Antagonists; Databases, Factual; Dementia; Dopamine Agonists; Drug Prescriptions; Drug Utilization; Geriatrics; Humans; Levodopa; Male; Medicine; Middle Aged; Neurology; Northwestern United States; Parkinson Disease; Practice Patterns, Physicians'; Primary Health Care; Psychiatry; Psychology; Retrospective Studies; Selegiline; Specialization; United States; United States Department of Veterans Affairs; Veterans	2006
Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Drug Therapy, Combination; Female; Functional Laterality; Humans; Levodopa; Male; Mental Status Schedule; Neurologic Examination; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor	2006
Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case. Neuropathology : official journal of the Japanese Society of Neuropathology, 2007, Volume: 27, Issue:3 Topics: Aged; Amyotrophic Lateral Sclerosis; Autopsy; Dementia; Diagnosis, Differential; Dopamine Agents; Fatal Outcome; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra	2007
Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:10 Topics: Aged; Antiparkinson Agents; Comorbidity; Dementia; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; REM Sleep Behavior Disorder; Statistics as Topic	2007
Homozygous SCA 2 mutations changes phenotype and hastens progression. Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-15, Volume: 23, Issue:5 Topics: Antiparkinson Agents; Ataxins; Dementia; Disease Progression; Dyskinesias; Female; Follow-Up Studies; Homozygote; Humans; Levodopa; Male; Mutation; Nerve Tissue Proteins; Ocular Motility Disorders; Parkinsonian Disorders; Phenotype; Psychotic Disorders; Spinocerebellar Degenerations	2008
The auditory startle response in parkinsonism may reveal the extent but not type of pathology. Journal of neurology, 2008, Volume: 255, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Auditory Pathways; Blinking; Brain Stem; Dementia; Diagnosis, Differential; Facial Muscles; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neck Muscles; Ocular Motility Disorders; Parkinsonian Disorders; Predictive Value of Tests; Reflex, Startle; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Tauopathies	2008
The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-30, Volume: 23, Issue:6 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Australia; Dementia; Dyskinesias; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	2008
Levodopa and receptor sensitivity modification in tardive dyskinesia. Psychopharmacology, 1982, Volume: 78, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Benserazide; Bipolar Disorder; Dementia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Receptors, Dopamine; Schizophrenia	1982
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta neurologica Scandinavica, 1981, Volume: 64, Issue:2 Topics: Aged; Alzheimer Disease; Butyrophenones; Dementia; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Phenothiazines; Phenylacetates	1981
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. Archives of neurology, 1980, Volume: 37, Issue:6 Topics: Brain Chemistry; Cerebellar Diseases; Creatine Kinase; Dementia; Diet; Encephalitis; Epilepsy; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hypoxia; Levodopa; Multiple Sclerosis; Muscular Dystrophies; Nervous System Diseases; Parkinson Disease; Tissue Preservation	1980
The natural history of Parkinson's disease. Australian family physician, 1984, Volume: 13, Issue:5 Suppl Topics: Activities of Daily Living; Dementia; Dysarthria; Gait; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Thalamus; Time Factors; Tremor	1984
Difficulties in long term management of Parkinson's disease. Australian family physician, 1984, Volume: 13, Issue:5 Suppl Topics: Dementia; Depression; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa; Parkinson Disease; Time Factors	1984
Symptoms and side effects in the course of Parkinson's disease. Journal of neural transmission. Supplementum, 1983, Volume: 19 Topics: Autonomic Nervous System Diseases; Dementia; Diagnosis, Differential; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine	1983
Normal pressure hydrocephalus and Parkinson's disease. Journal of neural transmission. Supplementum, 1983, Volume: 19 Topics: Aged; Cerebrospinal Fluid Shunts; Combined Modality Therapy; Dementia; Female; Gait; Humans; Hydrocephalus; Hydrocephalus, Normal Pressure; Levodopa; Male; Parkinson Disease; Tomography, X-Ray Computed	1983
Problems associated with long-term levodopa treatment of Parkinson's disease. Acta neurologica Scandinavica. Supplementum, 1983, Volume: 95 Topics: Dementia; Differential Threshold; Disability Evaluation; Humans; Intelligence; Levodopa; Parkinson Disease; Risk	1983
Diagnosis and management of parkinsonism in the elderly. Age and ageing, 1983, Volume: 12, Issue:4 Topics: Age Factors; Aged; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1983
[Effect of L-dopa on clinical duration and quality of life of patients with Parkinsonism-dementia in Guam]. Rinsho shinkeigaku = Clinical neurology, 1983, Volume: 23, Issue:11 Topics: Age Factors; Aged; Asian People; Dementia; Female; Guam; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Sex Factors	1983
Neuropsychological disturbances and cerebral atrophy determined by computerized tomography in parkinsonian patients with long-term levodopa treatment. Advances in neurology, 1984, Volume: 40 Topics: Brain; Cognition Disorders; Dementia; Humans; Levodopa; Parkinson Disease; Tomography, X-Ray Computed	1984
Epidemiological survey of dementia in parkinsonism and control population. Advances in neurology, 1984, Volume: 40 Topics: Age Factors; Dementia; Humans; Levodopa; Parkinson Disease; Sex Factors	1984
Mental disorders in Parkinson's disease after treatment with L-DOPA. Advances in neurology, 1984, Volume: 40 Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1984
Epidemiology of Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Adult; Aged; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Minnesota; Parkinson Disease	1984
What to do when Sinemet fails: Part one. Clinical neuropharmacology, 1984, Volume: 7, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Dementia; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1984
Levodopa: long-term impact on Parkinson's disease. British medical journal (Clinical research ed.), 1981, Feb-07, Volume: 282, Issue:6262 Topics: Atrophy; Cerebral Cortex; Dementia; Hallucinations; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1981
Behavioral alterations and the therapy of parkinsonism. Clinical neuropharmacology, 1982, Volume: 5 Suppl 1 Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced	1982
Confusion, dementia and anticholinergics in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1982, Volume: 45, Issue:12 Topics: Cognition Disorders; Confusion; Dementia; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1982
Senile parkinsonism, a study of current treatment. Age and ageing, 1981, Volume: 10, Issue:2 Topics: Aged; Carboxy-Lyases; Data Collection; Dementia; Dopamine Antagonists; England; Humans; Levodopa; Parkinson Disease; Phenothiazines	1981
CSF acetylcholinesterase in Parkinson disease: decreased enzyme activity and immunoreactivity in demented patients. Clinica chimica acta; international journal of clinical chemistry, 1995, Feb-28, Volume: 235, Issue:1 Topics: Acetylcholinesterase; Age Factors; Aged; Biomarkers; Dementia; Enzyme-Linked Immunosorbent Assay; Female; Humans; Levodopa; Male; Parkinson Disease; Sex Factors	1995
Visual evoked potentials (VEPs) in Parkinson's disease: correlation of pattern VEPs abnormality with dementia. Alzheimer disease and associated disorders, 1995,Summer, Volume: 9, Issue:2 Topics: Aged; Dementia; Dominance, Cerebral; Evoked Potentials, Visual; Female; Humans; Levodopa; Male; Mental Status Schedule; Occipital Lobe; Parkinson Disease; Pattern Recognition, Visual; Reaction Time	1995
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Creatine; Dementia; Energy Metabolism; Female; Humans; Lactates; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphocreatine; Protons	1995
Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta neurologica Scandinavica, 1994, Volume: 89, Issue:5 Topics: Adolescent; Adult; Brain Diseases; Carbidopa; Child; Chromosome Aberrations; Chromosome Disorders; Consanguinity; Dementia; Electromyography; Extrapyramidal Tracts; Female; Globus Pallidus; Humans; Immobilization; Levodopa; Magnetic Resonance Imaging; Male; Pedigree; Syndrome	1994
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication. Neuropsychologia, 1993, Volume: 31, Issue:9 Topics: Adult; Aged; Brain; Bromocriptine; Dementia; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Reaction Time; Task Performance and Analysis	1993
Parkinson's dementia and Alzheimer's dementia: an evoked potential comparison. Gerontology, 1993, Volume: 39, Issue:4 Topics: Aged; Alzheimer Disease; Dementia; Evoked Potentials; Evoked Potentials, Visual; Humans; Levodopa; Mental Status Schedule; Parkinson Disease; Reaction Time; Regression Analysis	1993
Antecedent clinical features associated with dementia in Parkinson's disease. Neurology, 1993, Volume: 43, Issue:9 Topics: Aged; Dementia; Depression; Humans; Levodopa; Middle Aged; Odds Ratio; Parkinson Disease; Prevalence; Psychoses, Substance-Induced; Risk Factors	1993
The clinical features of Parkinson's disease in 100 histologically proven cases. Advances in neurology, 1993, Volume: 60 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Corpus Striatum; Dementia; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Neurofibrillary Tangles; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Tissue Donors	1993
Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies? Advances in neurology, 1993, Volume: 60 Topics: Age Factors; Aged; Brain; Dementia; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Motor Activity; Motor Skills; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease	1993
Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Advances in neurology, 1993, Volume: 60 Topics: Aged; Antiparkinson Agents; Carbidopa; Clozapine; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced	1993
A clinicopathologic study of 100 cases of Parkinson's disease. Archives of neurology, 1993, Volume: 50, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease; Survival Analysis	1993
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:1 Topics: Aged; Dementia; Depression; Depressive Disorder; Disability Evaluation; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease; Psychomotor Performance; Reference Values; Tremor	1993
[Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up]. Neurologia (Barcelona, Spain), 1997, Volume: 12, Issue:3 Topics: Aged; Dementia; Depressive Disorder; Female; Humans; Levodopa; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales	1997
Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group. Neurology, 1998, Volume: 50, Issue:5 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Cognition; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance	1998
Hereditary form of parkinsonism--dementia. Annals of neurology, 1998, Volume: 43, Issue:6 Topics: Adult; Antiparkinson Agents; Choline O-Acetyltransferase; Dementia; Dopamine; Family Health; Female; Genes, Dominant; Hippocampus; Homovanillic Acid; Humans; Levodopa; Lewy Bodies; Locus Coeruleus; Male; Middle Aged; Neostriatum; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Pedigree; Substantia Innominata; Substantia Nigra; Temporal Lobe; Tomography, Emission-Computed	1998
[Dementia--Parkinson disease: role of antiglutamatergic drugs. Symposium: 4 April, Hamburg]. Fortschritte der Neurologie-Psychiatrie, 1998, Volume: 66, Issue:6 Suppl De Topics: Amantadine; Antipsychotic Agents; Dementia; Humans; Levodopa; Movement Disorders; Parkinson Disease; Selective Serotonin Reuptake Inhibitors	1998
Neurodegenerative disease: a different view of diagnosis. Molecular medicine today, 1999, Volume: 5, Issue:12 Topics: Alzheimer Disease; Dementia; Dopamine Agents; Humans; Levodopa; Lewy Bodies; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinson Disease; Prion Diseases; Synucleins; tau Proteins	1999
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:1 Topics: Age Distribution; Age of Onset; Aged; Antiparkinson Agents; Dementia; Depression; Disease Progression; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Prevalence; Psychotic Disorders; Risk Factors	2000
Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Dementia; Depression; Diabetes Mellitus; Drug Tolerance; Fatigue; Female; Humans; Levodopa; Male; Movement Disorders; Neurologic Examination; Norway; Outpatients; Parkinson Disease; Prevalence; Psychomotor Performance; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires	2000
Dopa-resistant parkinsonism, oculomotor disturbances, chorea, mirror movements, dyspraxia, and dementia: the expanding clinical spectrum of hypoparathyroidism. A case report. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:6 Topics: Aged; Antiparkinson Agents; Apraxias; Brain Diseases; Calcinosis; Chorea; Chronic Disease; Dementia; Diagnosis, Differential; Drug Tolerance; Female; Humans; Hypoparathyroidism; Levodopa; Magnetic Resonance Imaging; Oculomotor Nerve Diseases; Parkinsonian Disorders; Stereotypic Movement Disorder; Videotape Recording	2000
Establishment of L-3,4-Dihydroxyphenilalaninde-induced pharmacological dementia model mouse. Neuroscience letters, 2001, Jun-08, Volume: 305, Issue:2 Topics: Administration, Oral; Animals; Antiparkinson Agents; Avoidance Learning; Cognition Disorders; Dementia; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Stereoisomerism	2001
Relation between changes in long-latency stretch reflexes and muscle stiffness in Parkinson's disease--comparison before and after unilateral pallidotomy. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2001, Volume: 112, Issue:10 Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Dementia; Electromyography; Female; Functional Laterality; Globus Pallidus; Hand; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease; Reaction Time; Reflex, Stretch; Wrist Joint	2001
Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology, 2001, Dec-11, Volume: 57, Issue:11 Topics: Aged; Dementia; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors	2001
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain : a journal of neurology, 2002, Volume: 125, Issue:Pt 6 Topics: Aged; Analysis of Variance; Corpus Striatum; Dementia; Dopamine Agents; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed	2002
[Acute pharmacotoxic psychoses in patients with chronic cerebral disorders]. Wiener medizinische Wochenschrift. Supplement, 1979, Volume: 55 Topics: Aged; Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Cerebrovascular Disorders; Dementia; Digitalis Glycosides; Diuretics; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Psychoses, Substance-Induced	1979
Letter: Extrapyramidal dementia and levodopa. Lancet (London, England), 1975, Apr-05, Volume: 1, Issue:7910 Topics: Aged; Basal Ganglia Diseases; Dementia; Female; Humans; Levodopa; Male; Parkinson Disease	1975
Letter: Parkinsonism and dementia: effects of levodopa. Lancet (London, England), 1975, May-10, Volume: 1, Issue:7915 Topics: Dementia; Humans; Levodopa; Mental Processes; Parkinson Disease	1975
Letter: Parkinsonism and dementia: effects of levodopa. Lancet (London, England), 1975, May-31, Volume: 1, Issue:7918 Topics: Dementia; Electroencephalography; Humans; Levodopa; Parkinson Disease	1975
Levodopa boosts intellectual rating in senile dementia. JPMA. The Journal of the Pakistan Medical Association, 1978, Volume: 28, Issue:10 Topics: Dementia; Humans; Levodopa	1978
[Extrapyramidal and presenile dementia. Relation between symptoms of dementia and cerebral transmitters, particularly dopamine]. Ugeskrift for laeger, 1976, Aug-16, Volume: 138, Issue:34 Topics: Acetylcholine; Brain; Dementia; Dopamine; Humans; Levodopa; Parkinson Disease; Synaptic Transmission	1976
[Intellectual deterioration in Parkinson patients treated with L-dopa. Long-term prognostic factors]. International journal of neurology, 1979, Volume: 13, Issue:1-4 Topics: Dementia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis	1979
Dementia in Parkinson Disease. Annals of neurology, 1979, Volume: 6, Issue:4 Topics: Aged; Dementia; Female; Humans; Levodopa; Male; Parkinson Disease	1979
Levodopa in senile dementia. British medical journal, 1978, Jun-17, Volume: 1, Issue:6127 Topics: Dementia; Humans; Intelligence Tests; Levodopa	1978
Levodopa in senile dementia. British medical journal, 1978, Aug-12, Volume: 2, Issue:6135 Topics: Dementia; Dopamine; Female; Humans; Levodopa	1978
[Physical therapy and speech therapy in Parkinson syndrome--a status assessment]. Fortschritte der Neurologie-Psychiatrie, 1992, Volume: 60, Issue:10 Topics: Aged; Combined Modality Therapy; Dementia; Disability Evaluation; Female; Humans; Levodopa; Male; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Parkinson Disease, Secondary; Physical Therapy Modalities; Quality of Life; Speech Therapy	1992
Early-onset Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced; Risk Factors	1991
"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease. Neurology, 1991, Volume: 41, Issue:5 Topics: Aged; Analysis of Variance; Cohort Studies; Dementia; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Middle Aged; Motor Activity; Parkinson Disease	1991
Risk factors for dementia in Parkinson's disease. Advances in neurology, 1990, Volume: 53 Topics: Aged; Cardiovascular Diseases; Dementia; Diabetes Complications; Female; Humans; Levodopa; Male; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Risk Factors; Smoking	1990
[The mental state of parkinsonian patients]. La Revue du praticien, 1989, Mar-09, Volume: 39, Issue:8 Topics: Cognition Disorders; Dementia; Depression; Humans; Levodopa; Mental Disorders; Parkinson Disease	1989
Defective concept formation in parkinsonians is independent from mental deterioration. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:3 Topics: Aged; Concept Formation; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychometrics	1989
Problems in the contemporary treatment of parkinsonism. The Medical journal of Australia, 1985, Jan-21, Volume: 142, Issue:2 Topics: Basal Ganglia; Dementia; Humans; Kinetics; Levodopa; Movement Disorders; Neuromuscular Junction; Parkinson Disease; Receptors, Dopamine; Synaptic Transmission	1985
A woman with dementia and parkinsonism unresponsive to levodopa. The Medical journal of Australia, 1988, Nov-07, Volume: 149, Issue:9 Topics: Alzheimer Disease; Brain; Dementia; Female; Humans; Levodopa; Middle Aged; Neurons; Parkinson Disease	1988
Dementia and treatment with L-dopa in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1988, Volume: 3, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cognition; Dementia; Humans; Levodopa; Middle Aged; Parkinson Disease; Psychomotor Performance; Time Factors	1988
Biochemical aspects of Parkinson-dementia complex. European neurology, 1988, Volume: 28 Suppl 1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dementia; Female; Humans; Levodopa; Male; Mice; Middle Aged; Oxygen; Parkinson Disease; Pyridines; Serotonin; Tryptophan Hydroxylase	1988
[Levodopa therapy in a patient with ALS-dementia complex]. Rinsho shinkeigaku = Clinical neurology, 1987, Volume: 27, Issue:9 Topics: Amyotrophic Lateral Sclerosis; Dementia; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged	1987
Parkinson's disease: further steps forward. Gerontology, 1987, Volume: 33, Issue:6 Topics: Adrenal Medulla; Adult; Animals; Dementia; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurons; Oxazines; Parkinson Disease	1987
Nosography of Parkinson's disease. Journal of neural transmission. Supplementum, 1986, Volume: 22 Topics: Cognition; Dementia; Humans; Levodopa; Movement; Parkinson Disease	1986
Pharmacology of mental aging and dementia disorders. Clinical neuropharmacology, 1987, Volume: 10, Issue:4 Topics: Acetylcholine; Aging; Alzheimer Disease; Dementia; Humans; Levodopa; Neuropeptides	1987
Young onset Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:2 Topics: Adult; Age Factors; Circadian Rhythm; Dementia; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pedigree; Risk Factors; Tremor	1987
Long-term follow-up of early dopa treatment in Parkinson's disease. Annals of neurology, 1986, Volume: 19, Issue:4 Topics: Dementia; Disability Evaluation; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1986
[Clinical subtypes of Parkinson disease]. Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16 Topics: Dementia; Diagnosis, Differential; Follow-Up Studies; Humans; Levodopa; Neuropsychological Tests; Parkinson Disease; Tremor	1986
Predictive factors for cognitive deterioration and dementia in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Cognition Disorders; Dementia; Electroencephalography; Homovanillic Acid; Humans; Levodopa; Parkinson Disease; Prognosis	1987
Sixteen-year follow-up of 100 patients begun on levodopa in 1968: emerging problems. Advances in neurology, 1987, Volume: 45 Topics: Aged; Dementia; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Posture	1987
Results of investigations in 150 demented patients consecutively admitted to a psychiatric hospital. The British journal of psychiatry : the journal of mental science, 1985, Volume: 147 Topics: Aged; Alcoholism; Brain Neoplasms; Dementia; Female; Humans; Levodopa; Male; Meningioma; Middle Aged; Vitamin B 12 Deficiency	1985
Clinical features, etiology and treatment of facial dyskinesias in the elderly. Journal of the American Geriatrics Society, 1974, Volume: 22, Issue:11 Topics: Age Factors; Aged; Brain; Brain Damage, Chronic; Brain Stem; Chorea; Dementia; Dopamine; Face; Female; Haloperidol; Humans; Intracranial Arteriosclerosis; Levodopa; Lip; Male; Movement Disorders; Parasympathomimetics; Parkinson Disease; Phenothiazines; Tongue	1974